Evaluation of pulmonary hypertension in heart failure with preserved ejection fraction.

IF 4.2 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Heart Failure Reviews Pub Date : 2025-09-09 DOI:10.1007/s10741-025-10553-8

Jenny Jia Ling Cao, Yogesh N V Reddy

引用次数: 0

Abstract

In contemporary clinical practice, pulmonary hypertension (PH) is most commonly caused by heart failure with preserved ejection fraction (HFpEF). This high prevalence of HFpEF-related PH has contributed to complexity in diagnosis and evaluation of PH in the context of other diseases such as the presence of risk factors for group 1 PH. In this review, we discuss emerging concepts guiding the evaluation, pathobiology, and treatment of PH in patients with HFpEF or HFpEF-associated risk factors.

查看原文本刊更多论文

保留射血分数心力衰竭患者肺动脉高压的评价。

在当代临床实践中，肺动脉高压（PH）最常见的原因是心力衰竭保留射血分数（HFpEF）。HFpEF相关的PH的高患病率增加了在其他疾病背景下诊断和评估PH的复杂性，例如存在1组PH的危险因素。在这篇综述中，我们讨论了指导HFpEF或HFpEF相关危险因素患者PH评估、病理生物学和治疗的新兴概念。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Heart Failure Reviews 医学-心血管系统

CiteScore

10.40

自引率

2.20%

发文量

审稿时长

6-12 weeks

期刊介绍： Heart Failure Reviews is an international journal which develops links between basic scientists and clinical investigators, creating a unique, interdisciplinary dialogue focused on heart failure, its pathogenesis and treatment. The journal accordingly publishes papers in both basic and clinical research fields. Topics covered include clinical and surgical approaches to therapy, basic pharmacology, biochemistry, molecular biology, pathology, and electrophysiology. The reviews are comprehensive, expanding the reader''s knowledge base and awareness of current research and new findings in this rapidly growing field of cardiovascular medicine. All reviews are thoroughly peer-reviewed before publication.